Molecular Clonality of Uropathogenic E. Coli

尿路致病性大肠杆菌的分子克隆

• 批准号: 8639068
• 负责人: EVGENI Veniaminovic SOKURENKO
• 金额: $ 78.43万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-11-19 至 2018-10-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8639068
• 关键词: Acute; Antibiotics; Bacterial Infections; Bioinformatics; Biological Assay; Clinical; Clonality; Code; Collection; Communities; Cystitis; Data; Data Analyses; Databases; Epidemic; Epidemiology; Escherichia coli; Experimental Models; Fimbrial Adhesins; Functional RNA; Gene Mutation; Gene Transfer; Genes; Genetic; Genetic Transcription; Genetic Variation; Genome; Genomics; Genotype; Geographic Locations; Goals; Health; Health Personnel; High-Throughput Nucleotide Sequencing; Horizontal Gene Transfer; Housekeeping; Human; In Vitro; Infection; Investigation; Maps; Measures; Microbial Biofilms; Molecular; Molecular Epidemiology; Mutation; Pathogenesis; Pathogenicity; Patients; Phylogenetic Analysis; Population; Preventive; Primary Health Care; Prophylactic treatment; Public Health; Recurrence; Research; Research Personnel; Resistance; Resources; Sampling; Single Nucleotide Polymorphism; Stratification; Structure; Testing; Therapeutic; Time; Universities; Urinary tract infection; Uropathogen; Uropathogenic E. coli; Vaccine Therapy; Vaccines; Virulence; Washington; Woman; bacterial resistance; base; capsule; colanic acid; comparative; expectation; genome analysis; genome sequencing; genome-wide; genome-wide analysis; in vivo; insertion/deletion mutation; killings; mouse model; mucoid; neutrophil; nosocomial UTI; novel; public health relevance; research study; tool; trait

DESCRIPTION (provided by applicant): Our long-term goal is to advance the understanding, at the molecular level, of the pathogenicity and epidemiology of uropathogenic Escherichia coli (UPEC) strains to better target treatment and prophylaxis of urinary tract infections, reduce resistance, and provide information on possible targets for vaccines and antibiotics. The proposed studies are focused on understanding the basis of urovirulence of E. coli by the comparative genome-wide analysis of strains that will be isolated from a large number of patients with first-time and recurrent cystitis and healthy women. The central hypothesis is that the relatively few clonal groups involved in UPEC human pathogenesis can be defined and characterized as to their key genetic loci and the impact of genetic variations on UPEC virulence. Our preliminary data support that we can investigate sizeable samples of fresh isolates, establish strong clonal associations with recurrent cystitis and determine genome- wide the pathogenicity-adaptive genetic changes. We will determine how mutational changes (single nucleotide polymorphisms, small insertions/deletions, etc) and horizontal gene transfer contribute to the emergence of UPEC. Our aim is to potentially examine every gene shared by at least a portion of UPEC strains for being under positive selection for pathogenicity-adaptive mutations or horizontal transfer. For this, we will employ a population genomics-based analysis to trace the mutations and gene transfer, followed by assessment of the functional significance of the representative positively selected loci in UPEC.

描述（由申请人提供）：我们的长期目标是在分子水平上推进对尿路致病性大肠杆菌（UPEC）菌株的致病性和流行病学的理解，以更好地靶向治疗和预防尿路感染，减少耐药性，并提供关于疫苗和抗生素可能靶点的信息。拟议的研究重点是通过对将从大量首次和复发性膀胱炎患者和健康女性中分离的菌株进行全基因组比较分析，了解大肠杆菌泌尿毒性的基础。中心假设是，相对较少的与UPEC人类发病机制相关的克隆群可以根据其关键遗传位点和遗传变异对UPEC毒力的影响来定义和表征。我们的初步数据支持我们可以调查大量新鲜分离物样本，建立与复发性膀胱炎的强克隆关联，并确定全基因组范围内的致病性适应性遗传变化。我们将确定突变变化（单核苷酸多态性，小插入/缺失等）和水平基因转移如何促进UPEC的出现。我们的目标是潜在地检查至少一部分UPEC菌株共享的每个基因是否处于致病性适应性突变或水平转移的正选择下。为此，我们将采用基于群体基因组学的分析来追踪突变和基因转移，然后评估upc中具有代表性的正选择位点的功能意义。